ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

ClinicalTrials.gov ID: NCT05852431

Public ClinicalTrials.gov record NCT05852431. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia (SHTG): The ENTRUST Study

Study identification

NCT ID
NCT05852431
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
89bio, Inc.
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

  • Pegozafermin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2023
Primary completion
Jul 6, 2025
Completion
Mar 31, 2026
Last update posted
Aug 6, 2025

2023 – 2026

United States locations

U.S. sites
73
U.S. states
26
U.S. cities
68
Facility City State ZIP Site status
89bio Clinical Study Site Chandler Arizona 85712
89bio Clinical Study Site Peoria Arizona 85381
89Bio Clinical Study Site Tucson Arizona 85712
89bio Clinical Study Site Conway Arkansas 72032
89bio Clinical Study Site Jonesboro Arkansas 72401
89bio Clinical Study Site Little Rock Arkansas 72205
89bio Clinical Trial Site Huntington Park California 90255
89Bio Clinical Study Site Long Beach California 90815
89bio Clinical Study Site Los Angeles California 90057
89bio Clinical Trial Site Northridge California 91325
89bio Clinical Trial Site Panorama City California 91402
89bio Clinical Study Site Santa Ana California 92705
89bio Clinical Trial Site Santa Ana California 92705
89bio Clinical Study Site Thousand Oaks California 91360
89Bio Clinical Study Site Tustin California 92780
89bio Clinical Study Site Wheat Ridge Colorado 80033
89bio Clinical Trial Site Wheat Ridge Colorado 80033
89bio Clinical Study Site Bridgeport Connecticut 06610
89Bio Clinical Study Site Clearwater Florida 33756
89bio Clinical Study Site Clearwater Florida 33761
89bio Clinical Study Site Hialeah Gardens Florida 33016
89Bio Clinical Study Site Homestead Florida 33030
89Bio Clinical Study Site Miami Lakes Florida 33014
89bio Clinical Study Site Miramar Florida 33027
89Bio Clinical Study Site Orlando Florida 32825
89bio Clinical Study Site Panama City Florida 32401
89bio Clinical Trial Site Port Orange Florida 32127
89Bio Clinical Study Site Tampa Florida 33606
89bio Clinical Study Site Atlanta Georgia 30309
89Bio Clinical Study Site Columbus Georgia 31904
89Bio Clinical Study Site Lawrenceville Georgia 30044
89Bio Clinical Study Site Chicago Illinois 60607
89bio Clinical Study Site West Des Moines Iowa 50265
89Bio Clinical Study Site Wichita Kansas 67205
89Bio Clinical Study Site Marrero Louisiana 70072
89bio Clinical Trial Site Shreveport Louisiana 71105
89Bio Clinical Study Site Oxon Hill Maryland 20745
89bio Clinical Study Site Flint Michigan 48504
89bio Clinical Trial Site Kansas City Missouri 64131
89bio Clinical Study Site St Louis Missouri 63110
89bio Clinical Study Site Las Vegas Nevada 89106
89bio Clinical Study Site Las Vegas Nevada 89118
89bio Clinical Study Sites Sparta New Jersey 07871
89bio Clinical Study Site East Syracuse New York 13057
89bio Clinical Trial Site New Windsor New York 12553
89bio Clinical Trial Site New York New York 10029
89Bio Clinical Study Site North Massapequa New York 11758
89bio Clinical Trial Site Richmond Hill New York 77379
89bio Clinical Trial Site Syracuse New York 13057
89Bio Clinical Study Site Morganton North Carolina 28655
89bio Clinical Study Site Cincinnati Ohio 45227
89bio Clinical Trial Site Columbus Ohio 43213
89bio Clinical Study Site Middleburg Heights Ohio 44130
89bio Clinical Study Site Stow Ohio 44224
89bio Clinical Study Site Oklahoma City Oklahoma 73102
89Bio Clinical Study Site Eugene Oregon 97404
89bio Clinical Study Site Charleston South Carolina 29414
89Bio Clinical Study Site Chattanooga Tennessee 37421
89bio Clinical Trial Site Clarksville Tennessee 37040
89bio Clinical Study Site Tullahoma Tennessee 37388
89bio Clinical Study Site Amarillo Texas 79106
89 Clinical Study Site Austin Texas 78757
89bio Clinical Study Site Dallas Texas 75226
89bio Clinical Study Site Graham Texas 76450
89bio Clinical Study Site Houston Texas 77030
89Bio Clinical Study Site Lampasas Texas 76550
89bio Clinical Study Site Mansfield Texas 76063
89bio Clinical Trial Site San Antonio Texas 78207
89bio Clinical Study Site San Antonio Texas 78209
89bio Clinical Study Site Wichita Falls Texas 76301
89bio Clinical Trial Site Salt Lake City Utah 84107
89Bio Clinical Study Site Burke Virginia 22015
89bio Clinical Trial Site Richmond Virginia 23249

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05852431, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05852431 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →